Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome (communities of bacteria) of infants with cystic fibrosis (CF) compared to that of healthy infants, and how these alterations may adversely affect their health.
FDA OKs Second Gene Therapy for Hemophilia B
The FDA has approved a second gene therapy for adults with hemophilia B, drugmaker Pfizer announced on Friday. The approval of fidanacogene elaparvovec (Beqvez) stipulates
April 27, 2024